Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants (Q24610169)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants
scientific article

    Statements

    Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants (English)
    0 references
    J K Hicks
    0 references
    J J Swen
    0 references
    C F Thorn
    0 references
    K Sangkuhl
    0 references
    E D Kharasch
    0 references
    V L Ellingrod
    0 references
    T C Skaar
    0 references
    D J Müller
    0 references
    A Gaedigk
    0 references
    J C Stingl
    0 references
    May 2013
    0 references
    93
    0 references
    5
    0 references
    402-8
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit